Telix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $8.93-$30.36 |
Market Cap | $5.2B |
Shares Short | 118,599 |
Financials
See moreRevenue (12 Mos) | $645.6M |
Revenue Growth (YoY) | 58.1% |
Gross Profit (12 Mos) | $405.3M |
Diluted EPS | $0.09 |
News
See moreYahoo Finance • 2 days ago
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Yahoo Finance • 8 days ago
CMS Grants Transitional Pass-Through Status for Gozellix
Yahoo Finance • 12 days ago
Telix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again -- Hagens Berman
Yahoo Finance • 13 days ago
Telix Pharmaceuticals Limited (TLX) Increases R&D by 47%, Progresses Key Prostate and Brain Cancer Trials
About
CEO | Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA |
Address | 55 Flemington Road, North Melbourne, VIC, Australia, 3051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
